Clinical and biologic features of patients suspected or confi rmed to have heparin-induced thrombocytopenia in a cardiothoracic surgical ICU

Chest

Volumn 142, Issue 4, 2012, Pages 837-844

  Trehel Tursis, Virginie ^a   Louvain Quintard, Virginie ^a   Zarrouki, Youssef ^a   Imbert, Audrey ^a   Doubine, Sylvie ^a   Stéphan, Franco̧is ^a  

^a CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG ANTIBODY; HEPARIN; HEPARIN ANTIBODY; LOW MOLECULAR WEIGHT HEPARIN; UNCLASSIFIED DRUG;

AGED; AREA UNDER THE CURVE; ARTICLE; ASSAY; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HEART SURGERY; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT MONITORING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SCORING SYSTEM; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; THORAX SURGERY; THROMBOCYTE COUNT; THROMBOSIS;

EID: 84867136859     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.11-3074     Document Type: Article

References (50)

1. Stéphan F, Hollande J, Richard O, et al. Thrombocytopenia in a surgical ICU. Chest. 1999;115(5):1363-1370. (Pubitemid 29230648)
2. Hui P, Cook DJ, Lim W, Fraser GA, Arnold DM. The frequency and clinical significance of thrombocytopenia complicating critical illness: a systematic review. Chest. 2011;139(2):271-278.
3. Napolitano LM, Warkentin TE, Almahameed A, Nasraway SA. Heparin-induced thrombocytopenia in the critical care setting: diagnosis and management. Crit Care Med. 2006;34(12):2898-2911. (Pubitemid 44808730)
4. Selleng K, Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia in intensive care patients. Crit Care Med. 2007; 35(4):1165-1176. (Pubitemid 46598970)
5. Shantsila E, Lip GYH, Chong BH. Heparin-induced thrombocytopenia A contemporary clinical approach to diagnosis and management. Chest. 2009;135(6):1651-1664.
6. Pouplard C, May MA, Iochmann S, et al. Antibodies to platelet factor 4-heparin after cardiopulmonary bypass in patients anticoagulated with unfractionated heparin or a low-molecular weight heparin: clinical implications for heparin-induced thrombocytopenia. Circulation. 1999;99(19):2530-2536. (Pubitemid 29228283)
7. Warkentin TE, Sheppard J-AI, Horsewood P, Simpson PJ, Moore JC, Kelton JG. Impact of the patient population on the risk for heparin-induced thrombocytopenia . Blood. 2000;96(5):1703-1708. (Pubitemid 30661052)
8. Demma LJ, Levy JH. Diagnosing heparin-induced thrombocytopenia in cardiac surgical patients: not as easy as you think. Anesth Analg. 2011;112(4):747-749.
9. Lo GK, Juhl D, Warkentin TE, Sigouin CS, Eichler P, Greinacher A. Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. J Thromb Haemost. 2006;4(4):759-765.
10. Davies JO, Patel P, Zoumot Z. Diagnosing heparin induced thrombocytopenia in critically ill patients. Intensive Care Med. 2010;36(8):1447-1448.
11. Crowther MA, Cook DJ, Albert M, et al Canadian Critical Care Trials Group. The 4Ts scoring system for heparin-induced thrombocytopenia in medical-surgical intensive care unit patients. J Crit Care. 2010;25(2):287-293.
12. Demma LJ, Winkler AM, Levy JH. A diagnosis of heparin-induced thrombocytopenia with combined clinical and laboratory methods in cardiothoracic surgical intensive care unit patients . Anesth Analg. 2011;113(4):697-702.
13. Berry C, Tcherniantchouk O, Ley EJ, et al. Overdiagnosis of heparin-induced thrombocytopenia in surgical ICU patients. J Am Coll Surg. 2011;213(1):10-17., discussion 17-18.
14. Thielmann M, Bunschkowski M, Tossios P, et al. Perioperative thrombocytopenia in cardiac surgical patients-incidence of heparin-induced thrombocytopenia, morbidities and mortality. Eur J Cardiothorac Surg. 2010;37(6):1391-1395.
15. Sakr Y, Haetscher F, Gonsalves MD, et al . Heparin-induced thrombocytopenia type II in a surgical intensive care unit [published online ahead of print August 18, 2011]. J Crit Care.
16. Feinstein AR, Pritchett JA, Schimpff CR. The epidemiology of cancer therapy. IV. The extraction of data from medical records. Arch Intern Med. 1969;123(5):571-590.
17. Bernard GR, Artigas A, Brigham KL, et al. The American- European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994;149(3 pt 1):818-824. (Pubitemid 24082248)
18. Bone RC, Balk RA, Cerra FB, et al The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine . Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest. 1992;101(6):1644-1655.
19. Pouplard C, Amiral J, Borg JY, Laporte-Simitsidis S, Delahousse B, Gruel Y. Decision analysis for use of platelet aggregation test, carbon 14-serotonin release assay, and heparin-platelet factor 4 enzyme-linked immunosorbent assay for diagnosis of heparin-induced thrombocytopenia. Am J Clin Pathol. 1999;111(5):700-706. (Pubitemid 29200959)
20. Griner PF, Mayewski RJ, Mushlin AI, Greenland P. Selection and interpretation of diagnostic tests and procedures. Principles and applications. Ann Intern Med. 1981;94(4 pt 2):557-592.
21. Cuker A. Heparin-induced thrombocytopenia (HIT) in 2011: an epidemic of overdiagnosis. Thromb Haemost. 2011;106(6):993-994.
22. Bauer TL, Regally G, Knolled BA, et al. Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery. Circulation. 1997;95(5):1242-1246. (Pubitemid 27097836)
23. Pouplard C, May MA, Regina S, Marchand M, Fusciardi J, Gruel Y. Changes in platelet count after cardiac surgery can effectively predict the development of pathogenic heparindependent antibodies. Br J Haematol. 2005;128(6):837-841. (Pubitemid 40444878)
24. Warkentin TE. HIT paradigms and paradoxes. J Thromb Haemost. 2011;9(suppl 1):105-117.
25. Verma AK, Levine M, Shalansky SJ, Carter CJ, Kelton JG. Frequency of heparin-induced thrombocytopenia in critical care patients. Pharmacotherapy. 2003;23(6):745-753. (Pubitemid 36629079)
26. Selleng S, Malowsky B, Strobel U, et al. Early-onset and persisting thrombocytopenia in post-cardiac surgery patients is rarely due to heparin-induced thrombocytopenia, even when antibody tests are positive. J Thromb Haemost. 2010;8(1):30-36.
27. Warkentin TE, Sheppard JI, Moore JC, Sigouin CS, Kelton JG. Quantitative interpretation of optical density measurements using PF4-dependent enzyme-immunoassays. J Thromb Haemost. 2008;6(8):1304-1312. (Pubitemid 352016309)
28. Weiss BM, Shumway NM, Howard RS, Ketchum LK, Reid TJ. Optical density values correlate with the clinical probability of heparin induced thrombocytopenia. J Thromb Thrombolysis. 2008;26(3):243-247.
29. Ruf KM, Bensadoun ES, Davis GA, Flynn JD, Lewis DA. A clinical-laboratory algorithm incorporating optical density value to predict heparin-induced thrombocytopenia. Thromb Haemost. 2011;105(3):553-559.
30. Selleng S, Selleng K, Wollert HG, et al. Heparin-induced thrombocytopenia in patients requiring prolonged intensive care unit treatment after cardiopulmonary bypass. J Thromb Haemost. 2008;6(3):428-435. (Pubitemid 351280109)
31. Pouplard C, Gueret P, Fouassier M, et al. Prospective evaluation of the '4Ts' score and particle gel immunoassay specific to heparin/PF4 for the diagnosis of heparin-induced thrombocytopenia. J Thromb Haemost 2007; 5 (7) : 1373-1379. (Pubitemid 46965362)
32. Bryant A, Low J, Austin S, Joseph JE. Timely diagnosis and management of heparin-induced thrombocytopenia in a frequent request, low incidence single centre using clinical 4Ts score and particle gel immunoassay. Br J Haematol. 2008; 143(5):721-726.
33. Cook D, Crowther M, Meade M, et al. Deep venous thrombosis in medical-surgical critically ill patients: prevalence, incidence, and risk factors. Crit Care Med 2005;33(7):1565-1571. (Pubitemid 40980613)
34. Wester JPJ, Haas FJLM, Biesma DH, Leusink JA, Veth G. Thrombosis and hemorrhage in heparin-induced thrombocytopenia in seriously ill patients. Intensive Care Med. 2004;30(10):1927-1934. (Pubitemid 39468415)
35. Greinacher A, Farner B, Kroll H, Kohlmann T, Warkentin TE, Eichler P. Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis. A retrospective analysis of 408 patients. Thromb Haemost. 2005;94(1): 132-135. (Pubitemid 40974717)
36. Elalamy I, Tardy-Poncet B, Mulot A, et al; GEHT HIT Study Group . Risk factors for unfavorable clinical outcome in patients with documented heparin-induced thrombocytopenia. Thromb Res. 2009;124(5):554-559.
37. Warkentin TE, Kelton JG. A 14-year study of heparininduced thrombocytopenia. Am J Med. 1996;101(5):502-507.
38. Wallis DE, Workman DL, Lewis BE, Steen L, Pifarre R, Moran JF. Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia. Am J Med. 1999;106(6):629-635. (Pubitemid 29279299)
39. Makhoul RG, Greenberg CS, McCann RL. Heparin-associated thrombocytopenia and thrombosis: a serious clinical problem and potential solution. J Vasc Surg. 1986;4(5):522-528. (Pubitemid 17183331)
40. Hong AP, Cook DJ, Sigouin CS, Warkentin TE. Central venous catheters and upper-extremity deep-vein thrombosis complicating immune heparin-induced thrombocytopenia. Blood. 2003;101(8):3049-3051. (Pubitemid 36857994)
41. Zwicker JI, Uhl L, Huang W-Y, Shaz BH, Bauer KA. Thrombosis and ELISA optical density values in hospitalized patients with heparin-induced thrombocytopenia. J Thromb Haemost. 2004;2(12):2133-2137. (Pubitemid 40185772)
42. Altuntas F, Matevosyan K, Burner J, Shen Y-M, Sarode R. Higher optical density of an antigen assay predicts thrombosis in patients with heparin-induced thrombocytopenia. Eur J Haematol. 2008;80(5):429-435. (Pubitemid 351503102)
43. Tardy B, Presles E, Akrour M, de Maistre E, Lecompte T, Tardy-Poncet B. Experts' opinion or the serotonin release assay as a gold standard for the diagnosis of heparin-induced thrombocytopenia (HIT)? J Thromb Haemost. 2011;9(8):1667-1669.
44. Cuker A, Arepally G, Crowther MA, et al. The HIT Expert Probability (HEP) Score: a novel pre-test probability model for heparin-induced thrombocytopenia based on broad expert opinion. J Thromb Haemost. 2010;8(12):2642-2650.
45. Warkentin TE. Clinical presentation of heparin-induced thrombocytopenia. Semin Hematol. 1998;35(4)(suppl 5):9-16. (Pubitemid 28549557)
46. Nijsten MW, ten Duis H-J, Zijlstra JG, et al. Blunted rise in platelet count in critically ill patients is associated with worse outcome. Crit Care Med. 2000;28(12):3843-3846. (Pubitemid 32044482)
47. Akca S, Haji-Michael P, de Mendonça A, Suter P, Levi M, Vincent J-L. Time course of platelet counts in critically ill patients. Crit Care Med. 2002;30(4):753-756. (Pubitemid 34297789)
48. Magnani HN, Gallus A. Heparin-induced thrombocytopenia (HIT). A report of 1,478 clinical outcomes of patients treated with danaparoid (Orgaran) from 1982 to mid-2004. Thromb Haemost. 2006;95(6):967-981. (Pubitemid 43933754)
49. Lo GK, Sigouin CS, Warkentin TE. What is the potential for overdiagnosis of heparin-induced thrombocytopenia? Am J Hematol. 2007;82(12):1037-1043. (Pubitemid 350209843)
50. Warkentin TE, Greinacher A, Koster A, Lincoff AM; American College of Chest Physicians. Treatment and prevention of heparin-induced thrombocytopenia [published correction appears in Chest. 2011;139(5):1261]. Chest. 2008;133(suppl 6):340S-380S.